Financial Architects (New Jersey)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-50
Closed -$4K 427
2020
Q2
$4K Hold
50
﹤0.01% 749
2020
Q1
$3K Hold
50
﹤0.01% 749
2019
Q4
$5K Hold
50
﹤0.01% 761
2019
Q3
$5K Hold
50
﹤0.01% 824
2019
Q2
$6K Buy
+50
New +$5.04K ﹤0.01% 971
2018
Q4
Sell
-3,285
Closed -$225K 1375
2018
Q3
$259K Sell
3,285
-1,535
-32% -$100K 0.04% 263
2018
Q2
$288K Sell
4,820
-2,050
-30% -$110K 0.05% 229
2018
Q1
$277K Buy
6,870
+1,805
+36% +$88K 0.05% 243
2017
Q4
$266K Buy
5,065
+1,590
+46% +$84.9K 0.04% 275
2017
Q3
$164K Sell
3,475
-820
-19% -$33K 0.03% 379
2017
Q2
$152K Buy
4,295
+2,035
+90% +$62.8K 0.03% 379
2017
Q1
$53K Buy
2,260
+1,760
+352% +$34.9K 0.01% 638
2016
Q4
$7K Sell
500
-150
-23% -$2.42K ﹤0.01% 1081
2016
Q3
$12K Buy
+650
New +$11.5K ﹤0.01% 959

Other funds holding EXAS

Financial Architects (New Jersey)'s EXAS Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of Exact Sciences (EXAS) in Q3 2020, closing a stake of 50 shares — an estimated $4K sold.

Financial Architects (New Jersey) first reported a position in EXAS in Q3 2016 and held it in 14 quarters. The position peaked at $288K in Q2 2018. 517 funds tracked by Wall St. Rank hold EXAS as of Q3 2020.

  • Financial Architects (New Jersey) reported no remaining Exact Sciences position as of Q3 2020 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 50 Exact Sciences shares in Q3 2020, an estimated $4K.
  • Financial Architects (New Jersey) first reported a position in Exact Sciences in Q3 2016 and held it in 14 quarters.
  • Financial Architects (New Jersey)'s Exact Sciences position peaked at $288K in Q2 2018.
  • 517 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.